Published pricing · Provider review
RxActivate review: what semaglutide at $249 a month actually costs
RxActivate is one of the few GLP-1 telehealth platforms that prints a number before it asks for your medical history. That makes it one of the few we can carry out to a term total instead of writing “not computable” — so that is what this review does.
Published · Rates as published by RxActivate on that date · Editorial score 8.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Most of this vertical quotes after intake. You answer thirty questions about your weight, your history and your card details, and only then does a number appear. RxActivate does the opposite: semaglutide $249 a month, tirzepatide $399, branded Ozempic and Zepbound $1,200 each, NAD+ and sermorelin $239 — all on the product page, before anything is asked of you.
That is worth something on its own. It is also the entire reason this review can do arithmetic that most of our provider pages cannot.
The short answer
- Best reason to use it
- You can budget before you commit. A three-month semaglutide course is $747 and you know that before handing over a health history.
- Biggest unknown
- What the $249 buys. The page never says whether the cheaper injections are compounded or FDA-approved, while listing branded Ozempic beside them at nearly five times the price.
- Who should skip it
- Anyone who needs branded medication. At $14,400 a year, RxActivate’s Ozempic line is not a competitive way to buy an FDA-approved GLP-1.
What RxActivate costs over 3, 6 and 12 months
Every figure below is RxActivate’s published monthly rate multiplied by the term. It excludes anything billed separately, and it assumes the rate holds at your maintenance dose — which is the assumption most worth checking, because a dose escalation is where cheap GLP-1 pricing usually stops being cheap.
| Product | Per month | 3 months | 6 months | 12 months |
|---|---|---|---|---|
| Semaglutide injection | $249 | $747 | $1,494 | $2,988 |
| GLP-Squared injection | $250 | $750 | $1,500 | $3,000 |
| Tirzepatide injection | $399 | $1,197 | $2,394 | $4,788 |
| NAD+ | $239 | $717 | $1,434 | $2,868 |
| Sermorelin | $239 | $717 | $1,434 | $2,868 |
| Ozempic® | $1,200 | $3,600 | $7,200 | $14,400 |
| Zepbound® | $1,200 | $3,600 | $7,200 | $14,400 |
The twelve-month column is the one to sit with, and not because anyone signs up for a year. It is because a GLP-1 is not a course of antibiotics. Weight regain is likely after stopping, particularly without sustained changes to eating and activity, per the National Institute of Diabetes and Digestive and Kidney Diseases. Whatever you pay in month one is closer to a recurring line in your budget than a one-off, so$2,988 is the more honest way to read $249.
The $951 line item
RxActivate sells “Semaglutide Injection” at $249 and “Ozempic®” at $1,200. Same active molecule, $951 apart, on the same page, with no explanation of the difference. Over a year that gap is $11,412.
A spread that size almost always means the cheaper line is a compounded preparation rather than the branded product. We are not going to state that as fact, because RxActivate does not — but a buyer should not have to infer it either. Compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies and are not FDA-approved finished drug products, which means the agency has not reviewed them for safety, effectiveness or quality. Plenty of people choose them anyway, and at this price difference that is a rational choice. It should still be a choice you make with the answer in hand.
Ask before you pay: is the $249 semaglutide compounded or FDA-approved? It is one question, it has a one-word answer, and it changes what you are buying more than any other detail on the page.
Semaglutide or tirzepatide: an $1,800-a-year decision
The step from semaglutide to tirzepatide costs $150 a month at RxActivate — $1,800 over twelve. That is a real sum, and the clinical case for spending it is real too: tirzepatide adds GIP receptor activity to the GLP-1 mechanism, and direct comparative research has associated it with greater average weight reduction than semaglutide.
The decision is not yours alone to make, though, and RxActivate is clear about that: a licensed provider determines what is appropriate, and no prescription is issued otherwise. Treat the $150 as information for the consultation rather than a product you select from a shelf.
What RxActivate does well
- Publishes every rate before intake, in a category that mostly does not
- Both semaglutide and tirzepatide available, plus branded options for those who want them
- FSA and HSA eligible, and the published rates let you size the draw in advance
- Free monthly shipping, discreet packaging, entirely online
- States plainly that no prescription is issued unless a provider judges it appropriate
- LegitScript verification displayed
- One-month and three-month bundles rather than a long lock-in
Where it falls short
- Never states whether the $249 and $399 injections are compounded or FDA-approved
- GLP-Squared is priced but never defined
- Outcome figures of 85%, 60% and 50% are published with no source attached
- Consultation fees are generally non-refundable, including after a decline
- Medication refund window is referenced but not specified
- Publication logos are displayed without links to any coverage
- No state list — "nationwide" is qualified by licensure
Four things the price list does not tell you
- Whether the cheaper injections are compounded. The five-to-one gap against branded Ozempic points one way; the page says nothing either way.
- What GLP-Squared is. It is priced a dollar above semaglutide and described nowhere. A dollar tells you nothing, so the ingredients have to.
- How long the refund window runs. Medication refunds are limited to unopened, unexpired product returned "within a specified timeframe" — the timeframe is not specified.
- Where the outcome statistics come from. The 85% / 60% / 50% body-weight figures carry no study, no cohort and no date. RxActivate’s own caveat, that results vary with health factors, adherence and duration, sits directly above them.
None of these is disqualifying. All four are answerable in a single message to the company, and a platform confident enough to publish $249 on the open page should be comfortable answering them.
How the program runs
Three steps, and no surprises in any of them. You complete a questionnaire from home, including which of four weight-loss goal bands you fall into. A licensed provider reviews it, confirms safe use and builds a treatment plan, requesting baseline labs where your history or the specific treatment calls for them. Medication then ships monthly with free shipping, with support from the clinical team through the platform.
The middle step is where the money is at risk, not the third. If the provider declines to prescribe, the program stops there — and the consultation fee that produced the decline is described as generally non-refundable once completed. That is defensible, and it is also the sort of thing worth knowing before rather than after.
Who it suits
RxActivate fits the self-pay buyer who is comparing monthly rates across four or five tabs and is tired of the ones that will not show a number. If you are budgeting FSA or HSA funds, the published pricing is the difference between planning and guessing. And if you have already decided that compounded medication is an acceptable trade for the price — a decision a lot of people make deliberately — this is a competitively priced way to act on it.
It suits you less if branded, FDA-approved medication is the point. $14,400 a year for Ozempic through a telehealth platform is not the route to it. It also suits you less if you want structured coaching rather than a prescription and a shipping cadence; RxActivate describes clinical support, not a behaviour-change program, and NIDDK notes that these medications work best combined with a lifestyle program.
RxActivate: common questions
What does RxActivate cost for a full year?
At the published rates, semaglutide runs $2,988 a year, tirzepatide $4,788, and the GLP-Squared injection $3,000. Branded Ozempic or Zepbound through RxActivate would be $14,400. Those are the monthly rates multiplied out, not quoted annual plans — RxActivate sells a one-month bundle and a three-month bundle, so confirm which term your rate applies to before you extrapolate.
Why is Ozempic $1,200 when RxActivate sells semaglutide for $249?
RxActivate does not explain the gap on its pricing page. Ozempic is the branded, FDA-approved product; a $951-a-month difference for the same active molecule is the pattern you see when the cheaper line is a compounded preparation. RxActivate never states that, which is exactly why it belongs at the top of your intake questions rather than in an assumption.
Is the GLP-Squared injection worth $1 more than semaglutide?
There is no way to tell from the published information. RxActivate lists GLP-Squared at $250 a month beside semaglutide at $249 but never says what it contains or how it is dosed. A dollar is not a meaningful price signal, so the decision has to rest on the ingredients — ask the prescribing clinician what they are before choosing it.
Does RxActivate lock you into a contract?
No. RxActivate states that you can discontinue treatment at any time and recommends consulting your provider first. The commitment risk sits in the bundles rather than a contract: a three-month bundle is money spent ahead of knowing how you tolerate the medication, and RxActivate limits medication refunds to unopened, unexpired product returned inside a window it does not publish.
What happens to the consultation fee if a provider will not prescribe?
RxActivate says no prescription is issued unless a provider determines treatment is medically appropriate, and separately that consultation fees are generally non-refundable once the consultation has been completed. Read those two statements together before you pay — being declined is a possible outcome, and the fee for the visit that declined you is not described as refundable.
Can I use FSA or HSA funds at RxActivate?
RxActivate lists its program as FSA eligible or HSA eligible. Because it publishes rates up front, you can work out the draw on those funds before committing — $747 for a three-month semaglutide course, $1,197 for tirzepatide — which is not possible at a provider that quotes only after intake.
Does RxActivate bill insurance?
RxActivate says it offers both self-pay and insurance, with coverage varying by plan. GLP-1 coverage is refused by a large share of plans, so the practical planning assumption is the published self-pay rate. Treat any insurance contribution as upside rather than as the basis for your budget.
Is RxActivate available in my state?
RxActivate describes its services as available nationwide, subject to provider licensure, state-specific regulations and clinical appropriateness. It publishes no state-by-state list, so the only definitive answer comes at the end of the intake quiz.
What else does RxActivate sell besides GLP-1s?
NAD+ and sermorelin, both listed at $239 a month, or $2,868 a year each at that rate. They sit alongside the weight loss products on the same page rather than in a separate longevity program.
The verdict
Publishing a price is a small act of respect for the buyer, and in this vertical it is rare enough to be a genuine differentiator. $249 for semaglutide and $399 for tirzepatide are competitive numbers, FSA and HSA eligibility takes a real bite out of both, and the program around them — licensed provider, monthly delivery, free shipping, cancel whenever — does what it says.
What keeps this short of a straightforward recommendation is that the transparency stops at the number. A page that will tell you the price but not the product, that prices GLP-Squared without defining it, and that publishes outcome percentages with no source, has been transparent about the easy thing. Everything we would want answered is answerable — it just is not answered yet.
Worth your shortlist if price is what you are optimising for and you go into the consultation with the four questions above. Confirm the compounding status, the bundle term and the refund window before you pay, and the arithmetic in this review becomes the arithmetic you can actually rely on.
Keep comparing
See how the rest of the market prices the same medications on the weight loss rankings, or read the head-to-head articles in the comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what RxActivate published on the date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Three-, six- and twelve-month totals are calculated from those published monthly rates and exclude anything billed separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by RxActivate, and does not sell treatment. Read our ranking methodology.